Literature DB >> 24012795

The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.

Jennifer M Wenzel1, Zu-In Su, Kerisa Shelton, Hiram M Dominguez, Victoria A von Furstenberg, Aaron Ettenberg.   

Abstract

Human cocaine users report that the initial "high" produced by cocaine administration is followed by an anxiogenic "crash". Given that cocaine has such robust and opposing properties, it is likely that both positive and negative effects of cocaine contribute to an individual's motivation to administer the drug. Despite this likelihood, the neurobiology underlying cocaine's dual processes remains unclear. While much literature supports a role for dopamine (DA) in cocaine reward, it is uncertain if DA also contributes to the drug's negative effects. Our laboratory has extensively utilized a modified conditioned place test to explore cocaine's opponent processes. In this paradigm rats develop conditioned place preferences (CPPs) for an environment paired with the immediate/positive effects of cocaine, and conditioned place aversions (CPAs) for an environment paired with the delayed/negative effects present 15-min after i.v. injection. In the current study rats were conditioned to associate an environment with either the immediate or delayed effects of i.v. cocaine (1mg/kg/0.1ml) 3h after i.p. pre-treatment with either the DA D1/D2 receptor antagonist cis-flupenthixol (0.5mg/kg/ml) or saline vehicle. As expected, vehicle-treated control animals developed the normal pattern of CPPs for cocaine's immediate effects or CPAs for the delayed effects of cocaine. However, while DA receptor antagonism prevented the expression of cocaine CPPs it did not alter the expression of cocaine-induced CPAs. These data confirm a role for DA transmission in cocaine reward but suggest that different neural pathways mediate the drug's negative/anxiogenic properties.
© 2013.

Entities:  

Keywords:  Aversion; Cocaine; Conditioned place preference; Dopamine; Reward; cis-Flupenthixol

Mesh:

Substances:

Year:  2013        PMID: 24012795      PMCID: PMC3844024          DOI: 10.1016/j.pbb.2013.08.014

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  98 in total

Review 1.  Neuroanatomy of dopamine: reward and addiction.

Authors:  Katherine H Taber; Deborah N Black; Linda J Porrino; Robin A Hurley
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

2.  Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism.

Authors:  C Rivier; W Vale
Journal:  Brain Res       Date:  1987-10-06       Impact factor: 3.252

3.  Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.

Authors:  S S Negus; N K Mello; X Lamas; J H Mendelson
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

4.  Tolerance and sensitization to the behavioral effects of cocaine in rats: relationship to benzodiazepine receptors.

Authors:  N E Goeders; B D Irby; C C Shuster; G F Guerin
Journal:  Pharmacol Biochem Behav       Date:  1997 May-Jun       Impact factor: 3.533

Review 5.  Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.

Authors:  L H Gold; M A Geyer; G F Koob
Journal:  NIDA Res Monogr       Date:  1989

6.  Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine.

Authors:  W H Church; J B Justice; L D Byrd
Journal:  Eur J Pharmacol       Date:  1987-07-23       Impact factor: 4.432

7.  The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.

Authors:  Thomas C Jhou; Stefanie Geisler; Michela Marinelli; Beth A Degarmo; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

Review 8.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

9.  Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.

Authors:  N D Volkow; G J Wang; J S Fowler; S J Gatley; Y S Ding; J Logan; S L Dewey; R Hitzemann; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  2 in total

1.  The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.

Authors:  Luis M Colon-Perez; Kelvin Tran; Khalil Thompson; Michael C Pace; Kenneth Blum; Bruce A Goldberger; Mark S Gold; Adriaan W Bruijnzeel; Barry Setlow; Marcelo Febo
Journal:  Neuropsychopharmacology       Date:  2016-03-21       Impact factor: 7.853

2.  CRF antagonism within the ventral tegmental area but not the extended amygdala attenuates the anxiogenic effects of cocaine in rats.

Authors:  Aaron Ettenberg; Samuel W Cotten; Michael A Brito; Adam K Klein; Tatum A Ohana; Benjamin Margolin; Alex Wei; Jennifer M Wenzel
Journal:  Pharmacol Biochem Behav       Date:  2015-10-08       Impact factor: 3.533

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.